169 related articles for article (PubMed ID: 38372202)
1. BioPrint meets the AI age: development of artificial intelligence-based ADMET models for the drug-discovery platform SAFIRE.
Biehn SE; Goncalves LM; Lehmann J; Marty JD; Mueller C; Ramirez SA; Tillier F; Sage CR
Future Med Chem; 2024 Apr; 16(7):587-599. PubMed ID: 38372202
[No Abstract] [Full Text] [Related]
2. ADMET-AI: A machine learning ADMET platform for evaluation of large-scale chemical libraries.
Swanson K; Walther P; Leitz J; Mukherjee S; Wu JC; Shivnaraine RV; Zou J
Bioinformatics; 2024 Jun; ():. PubMed ID: 38913862
[TBL] [Abstract][Full Text] [Related]
3. ADMET-AI: A machine learning ADMET platform for evaluation of large-scale chemical libraries.
Swanson K; Walther P; Leitz J; Mukherjee S; Wu JC; Shivnaraine RV; Zou J
bioRxiv; 2023 Dec; ():. PubMed ID: 38234753
[TBL] [Abstract][Full Text] [Related]
4. Artificial intelligence in small molecule drug discovery from 2018 to 2023: Does it really work?
Lv Q; Zhou F; Liu X; Zhi L
Bioorg Chem; 2023 Dec; 141():106894. PubMed ID: 37776682
[TBL] [Abstract][Full Text] [Related]
5. A Recent Appraisal of Artificial Intelligence and In Silico ADMET Prediction in the Early Stages of Drug Discovery.
Kumar A; Kini SG; Rathi E
Mini Rev Med Chem; 2021; 21(18):2788-2800. PubMed ID: 33797376
[TBL] [Abstract][Full Text] [Related]
6. Recent Studies of Artificial Intelligence on
Tran TTV; Tayara H; Chong KT
J Chem Inf Model; 2023 Oct; 63(20):6198-6211. PubMed ID: 37819031
[TBL] [Abstract][Full Text] [Related]
7. Machine Learning and Artificial Intelligence: A Paradigm Shift in Big Data-Driven Drug Design and Discovery.
Pasrija P; Jha P; Upadhyaya P; Khan MS; Chopra M
Curr Top Med Chem; 2022; 22(20):1692-1727. PubMed ID: 35786336
[TBL] [Abstract][Full Text] [Related]
8. AIDDISON: Empowering Drug Discovery with AI/ML and CADD Tools in a Secure, Web-Based SaaS Platform.
Rusinko A; Rezaei M; Friedrich L; Buchstaller HP; Kuhn D; Ghogare A
J Chem Inf Model; 2024 Jan; 64(1):3-8. PubMed ID: 38134123
[TBL] [Abstract][Full Text] [Related]
9. OptADMET: a web-based tool for substructure modifications to improve ADMET properties of lead compounds.
Yi J; Shi S; Fu L; Yang Z; Nie P; Lu A; Wu C; Deng Y; Hsieh C; Zeng X; Hou T; Cao D
Nat Protoc; 2024 Apr; 19(4):1105-1121. PubMed ID: 38263521
[TBL] [Abstract][Full Text] [Related]
10. Application of Artificial Intelligence and Machine Learning in Drug Discovery.
Gupta RR
Methods Mol Biol; 2022; 2390():113-124. PubMed ID: 34731466
[TBL] [Abstract][Full Text] [Related]
11. ADMETboost: a web server for accurate ADMET prediction.
Tian H; Ketkar R; Tao P
J Mol Model; 2022 Dec; 28(12):408. PubMed ID: 36454321
[TBL] [Abstract][Full Text] [Related]
12. Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery.
Tripathi MK; Nath A; Singh TP; Ethayathulla AS; Kaur P
Mol Divers; 2021 Aug; 25(3):1439-1460. PubMed ID: 34159484
[TBL] [Abstract][Full Text] [Related]
13. Big data and artificial intelligence (AI) methodologies for computer-aided drug design (CADD).
Lee JW; Maria-Solano MA; Vu TNL; Yoon S; Choi S
Biochem Soc Trans; 2022 Feb; 50(1):241-252. PubMed ID: 35076690
[TBL] [Abstract][Full Text] [Related]
14. Recent Studies of Artificial Intelligence on In Silico Drug Distribution Prediction.
Tran TTV; Tayara H; Chong KT
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768139
[TBL] [Abstract][Full Text] [Related]
15. Artificial Intelligence (AI) in Drugs and Pharmaceuticals.
Sahu A; Mishra J; Kushwaha N
Comb Chem High Throughput Screen; 2022; 25(11):1818-1837. PubMed ID: 34875986
[TBL] [Abstract][Full Text] [Related]
16. Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents.
Kashyap K; Siddiqi MI
Mol Divers; 2021 Aug; 25(3):1517-1539. PubMed ID: 34282519
[TBL] [Abstract][Full Text] [Related]
17. A primer on applying AI synergistically with domain expertise to oncology.
Kim J; Kusko R; Zeskind B; Zhang J; Escalante-Chong R
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188548. PubMed ID: 33901609
[TBL] [Abstract][Full Text] [Related]
18. Establishment and validation of an interactive artificial intelligence platform to predict postoperative ambulatory status for patients with metastatic spinal disease: a multicenter analysis.
Cui Y; Shi X; Qin Y; Wang Q; Cao X; Che X; Pan Y; Wang B; Lei M; Liu Y
Int J Surg; 2024 May; 110(5):2738-2756. PubMed ID: 38376838
[TBL] [Abstract][Full Text] [Related]
19. Machine learning and deep learning in data-driven decision making of drug discovery and challenges in high-quality data acquisition in the pharmaceutical industry.
Kumar SA; Ananda Kumar TD; Beeraka NM; Pujar GV; Singh M; Narayana Akshatha HS; Bhagyalalitha M
Future Med Chem; 2022 Feb; 14(4):245-270. PubMed ID: 34939433
[TBL] [Abstract][Full Text] [Related]
20. Artificial intelligence and big data facilitated targeted drug discovery.
Liu B; He H; Luo H; Zhang T; Jiang J
Stroke Vasc Neurol; 2019 Dec; 4(4):206-213. PubMed ID: 32030204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
